The County of Santa Clara v. Astra USA, Inc et al

Filing 686

ORDER REGARDING DEFENDANT AVENTIS'S OBJECTIONS TO PLAINTIFFS' DESIGNATION OF AMBIEN IN DISCOVERY REQUESTS. Signed by Judge Alsup on August 10, 2010. (whalc2, COURT STAFF) (Filed on 8/10/2010)

1 2 3 4 5 6 7 8 9 10 THE COUNTY OF SANTA CLARA, on behalf of itself and all others similarly situated, Plaintiffs, v. ASTRA USA, INC., ASTRA ZENECA PHARMACEUTICALS LP, EVENTS PHARMACEUTICALS, INC., BAYER CORPORATION, BRISTOL-MYERS SQUIBB COMPANY, PFIZER, INC., SCHERING-PLOUGH CORPORATION TAP PHARMACEUTICAL PRODUCTS, INC., ZENECCA, INC., ZLB BEHRING LLC, SMITHKLINE BEECHAM CORPORATION, SMITHKLINE BEECHAM CORPORATION d/b/a GLAXO SMITHKLINE, WYETH, INC., WYETH PHARMACEUTICALS, INC., Defendants. / IN THE UNITED STATES DISTRICT COURT FOR THE NORTHERN DISTRICT OF CALIFORNIA

United States District Court

11
For the Northern District of California

No. C 05-03740 WHA

12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

ORDER REGARDING DEFENDANT AVENTIS'S OBJECTIONS TO PLAINTIFFS' DESIGNATION OF AMBIEN IN DISCOVERY REQUESTS

Issued on July 9, 2010, the third amended case management order (Dkt. No. 667) is the operative scheduling order in this matter. Among other items, it ordered that each defendant must answer under oath two interrogatories regarding a single drug selected by plaintiffs for that defendant (July 9 order at 2). Defendant Aventis Pharmaceuticals Inc. has now filed an objection to the drug -- Ambien -- chosen by plaintiffs as to it. Aventis argues that Ambien is not a

1 2 3 4 5 6 7 8 9 10

product as issue in this action. Plaintiffs shall respond in a brief of no more than 5 pages no later than NOON ON THURSDAY, AUGUST 12, 2010.

IT IS SO ORDERED.

Dated: August 10, 2010.

WILLIAM ALSUP UNITED STATES DISTRICT JUDGE

United States District Court

11
For the Northern District of California

12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 2